Research Articles
Relational Autonomy in Asian Bioethics: Moving Beyond Western Frameworks for Medical Research and Practice
This article examines the critical limitations of applying Western, individualistic models of autonomy in Asian biomedical contexts.
The $1 Million Amendment: A Strategic Cost Comparison of Avoidable vs. Necessary Clinical Trial Changes
This article provides clinical researchers and drug development professionals with a data-driven framework to analyze, manage, and reduce clinical trial protocol amendments.
Navigating FDA and EMA Regulatory Differences for Successful Amendment Submissions
This article provides drug development researchers and regulatory professionals with a strategic guide to navigating the distinct regulatory landscapes of the FDA and EMA for submission amendments.
Navigating IRB Amendment Reviews: A Strategic Guide for Clinical Researchers and Drug Developers
This article provides a comprehensive guide for researchers and drug development professionals on navigating the Institutional Review Board (IRB) amendment review process.
Protocol Complexity and Amendments: Assessing Impact and Implementing Solutions for Efficient Clinical Trials
This article examines the critical relationship between clinical trial protocol complexity and the frequency of subsequent amendments, a major driver of cost and delay in drug development.
Protocol Amendments in Clinical Trials: A Comparative Analysis of Commercial vs. Academic Challenges and Solutions
This article provides a comprehensive analysis of protocol amendments in commercial and academic clinical trials, offering critical insights for researchers, scientists, and drug development professionals.
Navigating Change: A Comparative Analysis of Amendment Processes in Clinical Research, Regulation, and Governance
This article provides a comprehensive comparison of amendment processes across clinical research, regulatory, and constitutional systems.
Protocol Amendment Rates: A Comparative Analysis of Phase I vs Phase III Clinical Trials
This article provides a comprehensive analysis of protocol amendment rates, causes, and impacts in Phase I versus Phase III clinical trials.
Protocol Amendments and Clinical Trial Timelines: Current Impacts, Costs, and Optimization Strategies
This article examines the profound impact of protocol amendments on clinical trial efficiency, drawing on recent 2024 data.
Preventing Amendment-Related Protocol Deviations: A 2025 Strategic Guide for Clinical Researchers
This article provides clinical researchers and drug development professionals with a comprehensive framework for preventing protocol deviations stemming from amendments.